Evaluation of global laboratory methods and establishing on‐therapy ranges for monitoring apixaban and rivaroxaban: Experience at a single institution

BACKGROUND: Apixaban and rivaroxaban are approved for the prevention and treatment of deep vein thrombosis (DVT), pulmonary embolism (PE), and embolic stroke in atrial fibrillation (AF) patients. The aim of this study was to find appropriate methods of monitoring the anticoagulant effects of are dir...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Soon Ho, Seo, Yiel‐Hea, Park, Pil‐Whan, Kim, Kyung‐Hee, Seo, Ja Young, Lee, Hwan Tae, Kwoun, Woo‐Jae, Ahn, Jeong‐Yeal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595315/
https://www.ncbi.nlm.nih.gov/pubmed/30860622
http://dx.doi.org/10.1002/jcla.22869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595315/
https://www.ncbi.nlm.nih.gov/pubmed/30860622
http://dx.doi.org/10.1002/jcla.22869

Ejemplares similares